Rare diseases
Investigational molecules
Locations
Ul. Polskiego Czerwonego Krzyza 26, 33-100 Tarnow, Poland
Alergo Med Osrodek Badan Klinicznych Sp. z o.o. in Tarnow, Poland specialises in clinical trials of conditions such as Dermatitis atopic, Asthma, Chronic spontaneous urticaria, Cough, and other specialisations. This site conducts important research.
The medical center is at the forefront of Respiratory Medicine, focusing on innovative treatments for chronic respiratory conditions. The center's research is pivotal in enhancing the understanding and management of complex respiratory diseases.
By conducting cutting-edge clinical trials, the center contributes significantly to the development of new therapeutic strategies, improving patient outcomes and quality of life for those suffering from chronic respiratory ailments.
Clinical trials currently enrolling participants at this site.
A study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
PolandA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
PolandStudy on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen
PolandPharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis
PolandEfficacy and Safety of Inhaled Glycopyrronium Bromide Added to Budesonide and Formoterol Fumarate in Children 4‑12 Years with Asthma (Placebo‑Controlled)
PolandEfficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma
PolandA study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines
PolandA Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease
PolandSafety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne
PolandStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
PolandStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
PolandStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
